Metabolic and behavioral characteristics of metabolically obese but normal-weight women

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 10, 2004, Pages 5013-5020

  Conus, Florence ^a   Allison, David B ^b   Rabasa Lhoret, Remi ^a   St Onge, Maxime ^a   St Pierre, David H ^a   Tremblay Lebeau, Andréanne ^a   Poehlman, Eric T ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Scriptus Medicus   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GHRELIN; LEPTIN; LIPID; OXYGEN;

ADULT; ARTICLE; BEHAVIOR; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; ENERGY EXPENDITURE; FAMILY HISTORY; FEMALE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HUNGER; INSULIN SENSITIVITY; LIFESTYLE; LIPID BLOOD LEVEL; MEASUREMENT; METABOLIC RATE; METABOLIC SYNDROME X; OBESITY; OXYGEN CONSUMPTION; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SERUM; SITTING;

ADIPONECTIN; ADOLESCENT; ADULT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; COHORT STUDIES; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HEALTH BEHAVIOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MULTIVARIATE ANALYSIS; OBESITY; PEPTIDE HORMONES; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 6344254567     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0265     Document Type: Article

References (56)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79
2. Tremblay MS, Katzmarzyk PT, Willms JD 2002 Temporal trends in overweight and obesity in Canada, 1981-1996. Int J Obes Relat Metab Disord 26:538-543
3. Katzmarzyk PT 2002 The Canadian obesity epidemic, 1985-1998. Can Med Assoc J 166:1039-1040
4. Caterson ID, Gill TP 2002 Obesity: epidemiology and possible prevention. Best Pract Res Clin Endocrinol Metab 16:595-610
5. Ruderman NB, Schneider SH, Berchtold P 1981 The "metabolically- obese", normal-weight individual. Am J Clin Nutr 34:1617-1621
6. Ruderman NB, Chrisholm D, Pi-Sunyer X, Schneider SH 1998 The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713
7. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y 2003 Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26:2341-2344
8. Dvorak RV, DeNino WF, Ades PA, Poehlman ET 1999 Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 48:2210-2214
9. Ruderman NB, Berchtold P, Schneider SH 1982 Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 6:151-157
10. Friedewald WT, Levy RJ, Fredrickson DS 1972 Estimation of the concentration of low-density-lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turn RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
12. Weir JB 1949 New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9
13. Norton K, Olds T 2000 Anthropometrica, a textbook of body measurement for sports and health courses. Sydney: University of New South Wales Press
14. Taylor HL, Jacobs Jr DR, Schucker B, Knudsen J, Leon AS, Debracker G 1978 A questionnaire for the assessment of leisure time physical activity. J Chron Dis 31:741-755
15. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DRJ, Schmitz KH, Emplaincourt PO, Jacobs DRJ, Leon AS 2000 Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32 (Suppl):S498-S516
16. Health Canada 2001 The Canadian Nutrient File. Ottawa, Canada: Nutrition Research Division, Health Canada
17. Jequier E, Acheson K, Schutz Y 1987 Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 7:187-208
18. Stunkard AJ, Messick S 1985 The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29:71-83
19. Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM 1989 A comparison of the validity of three scales for the assessment of dietary restraint. J Abnorm Psychol 98:504-507
20. Anteile T 2002 Statistique - épidémiologie, collection sciences fondamentales. Paris, France: Maloine
21. Winer BJ 1991 Statistical principles in experimental design. New York: McGraw-Hill Book Company
22. Lovegrove JA, Silva KDRR, Wright JW, Williams CM 2002 Adiposity, insulin and lipid metabolism in post-menopausal women. Int J Obes 26:475-486
23. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL 1999 Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839-847
24. Carey DG, Jenkins AB, Campbell LV, Freund J, Chrisholm DJ 1996 Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638
25. Furler SM, Poynten AM, Kriketos AD, Lowy AJ, Ellis BA, Maclean EL, Courtenay BG, Kraegen EW, Campbell LV, Chrisholm DJ 2001 Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. Obes Res 9:535-543
26. Tai ES, Lau TN, Ho SC, Fok ACK, Tan CE 2000 Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes 24:751-757
27. Seidell JC, Muller DC, Sorkin JD, Andres R 1992 Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord 16:667-674
28. Ravussin E, Swinburn BA 1993 Metabolic predictors of obesity: cross-sectional versus longitudinal data. Int J Obes Relat Metab Disord 17(Suppl 3):S28-S31
29. Asturp A, Gotzsche PC, Van de Werken K, Ranneries C, Toubro S, Raben A, Buemann B 1999 Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr 69:1117-1122
30. Teff KL, Engelman K 1996 Palatability and dietary restraint: effect on cephalic phase insulin release in women. Physiol Behav 60:567-573
31. Tepper BJ 1992 Dietary restraint and responsiveness to sensory-based food cues as measured by cephalic phase salivation and sensory specific satiety. Physiol Behav 52:305-311
32. Anderson DA, Shapiro JR, Lundgren JD, Spataro LE, Frye CA 2002 Self reported dietary restraint is associated with elevated levels of salivary cortisol. Appetite 38:13-17
33. McLean JA, Barr SI, Prior JC 2001 Cognitive dietary restraint is associated with higher urinary cortisol excretion in healthy premenopausal women. Am J Clin Nutr 73:7-12
34. Pirke KM, Tuschl RJ, Spyra B, Laessle RG, Schweiger U, Brooks A, Sambauer S, Zitzelsberger G 1990 Endocrine findings in restrained eaters. Physiol Behav 47:903-906
35. Wang L, Saint-Pierre DH, Tache Y 2002 Peripheral ghrelin selectively increases Fos expression in neuropeptide Y-synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 325:47-51
36. Saint-Pierre DH, Wang L, Tache Y 2003 Ghrelin: a novel player in the gut-brain regulation of growth hormone and energy balance. News Physiol Sci 18:242-246
37. Fliers E, Kreier F, Voshol PJ, Havekes LM 2003 White adipose tissue: getting nervous. J Neuroendocrinol 15:1005-1010
38. Harvey J, Ashford ML 2003 Leptin in the CNS: much more than a satiety signal. Neuropharmacology 44:845-854
39. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
40. Purnell JQ, Weigle DS, Breen P, Cummings DE 2003 Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88:5747-5752
41. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O 2003 Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52:2546-2553
42. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ 2003 Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149:331-335
43. Gonzalez-Ortiz M, Martinez-Abundis E, Balcazar-Munoz BR 2000 Serum leptin concentrations in young insulin-sensitive and insulin-resistant volunteers. Horm Metab Res 32:273-276
44. Heini AF, Lara-Castro C, Kirk KA, Considine RV, Caro JF, Weinsier RL 1998 Association of leptin and hunger-satiety ratings in obese women. Int J Obes Relat Metab Disord 22:1084-1087
45. Tsofliou F, Pitsiladis YP, Malkova D, Wallace AM, Lean ME 2003 Moderate physical activity permits acute coupling between serum leptin and appetite-satiety measures in obese women. Int J Obes Relat Metab Disord 27:1332-1339
46. Matsubara M, Katayose S, Marioka S 2003 Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol 148:343-350
47. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S 2003 Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type II diabetes mellirus. Metabolism 52:1274-1278
48. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Sarata T 2002 Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103:137-142
49. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS 2003 Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat distribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 88:627-636
50. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G 2002 Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heat rate than those with optimal blood pressure. Diabetes Care 25:971-976
51. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
52. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, Louche-Pellisssier C, Maltrepierte C, Peyrat J, Chagne J, Vidal H, Laville M 2003 Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88:4917-4923
53. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M 2001 Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23:57-63
54. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H 1999 Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818-822
55. Hermans MP, Levy JC, Morris RJ, Turner RC 1999 Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678-687
56. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y, Nishizawa Y 2003 Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26:2426-2432